Literature DB >> 22156919

Structural features for α-galactomannan binding to galectin-1.

Michelle C Miller1, Anatole A Klyosov, Kevin H Mayo.   

Abstract

Galectins have a highly conserved carbohydrate-binding domain to which a variety of galactose-containing saccharides, both β- and α-galactosides, can interact with varying degrees of affinity. Recently, we demonstrated that the relatively large α(1 → 6)-D-galacto-β(1 → 4)-D-mannan (Davanat) binds galectin-1 (gal-1) primarily at an alternative carbohydrate-binding domain. Here, we used a series of α-galactomannans (GMs) that vary in their mannose-to-galactose ratios for insight into an optimal structural signature for GM binding to gal-1. Heteronuclear single-quantum coherence nuclear magnetic resonance spectroscopy with (15)N-labeled gal-1 and statistical modeling suggest that the optimal signature consists of α-D-galactopyranosyl doublets surrounded by regions of about four or more "naked" mannose residues. These relatively large and complex GMs all appear to interact with varying degrees at essentially the same binding surface on gal-1 that includes the Davanat alternative binding site and elements of the canonical β-galactoside-binding region. The use of two small, well-defined GMs [6(1)-α(1 → 6)-D-galactosyl-β-D-mannotriaose and 6(3),6(4)-di-α(1 → 6)-D-galactosyl-β-D-mannopentaose] helped characterize how GMs, in general, interact in part with the canonical site. Overall, our findings contribute to better understanding interactions of gal-1 with larger, complex polysaccharides and to the development of GM-based therapeutics for clinical use.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22156919      PMCID: PMC3287016          DOI: 10.1093/glycob/cwr173

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  20 in total

1.  On the galactosyl distribution of commercial galactomannans.

Authors:  P J Daas; H A Schols; H H de Jongh
Journal:  Carbohydr Res       Date:  2000-11-17       Impact factor: 2.104

2.  NMR View: A computer program for the visualization and analysis of NMR data.

Authors:  B A Johnson; R A Blevins
Journal:  J Biomol NMR       Date:  1994-09       Impact factor: 2.835

3.  NMRPipe: a multidimensional spectral processing system based on UNIX pipes.

Authors:  F Delaglio; S Grzesiek; G W Vuister; G Zhu; J Pfeifer; A Bax
Journal:  J Biomol NMR       Date:  1995-11       Impact factor: 2.835

4.  Galectin-1, an endogenous lectin produced by thymic epithelial cells, induces apoptosis of human thymocytes.

Authors:  N L Perillo; C H Uittenbogaart; J T Nguyen; L G Baum
Journal:  J Exp Med       Date:  1997-05-19       Impact factor: 14.307

5.  Demonstration of protein-protein interaction specificity by NMR chemical shift mapping.

Authors:  P Rajagopal; E B Waygood; J Reizer; M H Saier; R E Klevit
Journal:  Protein Sci       Date:  1997-12       Impact factor: 6.725

6.  Galectin-1 interacts with the {alpha}5{beta}1 fibronectin receptor to restrict carcinoma cell growth via induction of p21 and p27.

Authors:  Christian Fischer; Hugo Sanchez-Ruderisch; Martina Welzel; Bertram Wiedenmann; Toshiyuki Sakai; Sabine André; Hans-Joachim Gabius; Levon Khachigian; Katharina M Detjen; Stefan Rosewicz
Journal:  J Biol Chem       Date:  2005-08-16       Impact factor: 5.157

7.  Using pulse field gradient NMR diffusion measurements to define molecular size distributions in glycan preparations.

Authors:  Michelle C Miller; Anatole Klyosov; David Platt; Kevin H Mayo
Journal:  Carbohydr Res       Date:  2009-04-17       Impact factor: 2.104

8.  Exploring the structural diversity of mammalian carbohydrates ("glycospace") by statistical databank analysis.

Authors:  Daniel B Werz; René Ranzinger; Stephan Herget; Alexander Adibekian; Claus-Wilhelm von der Lieth; Peter H Seeberger
Journal:  ACS Chem Biol       Date:  2007-10-19       Impact factor: 5.100

9.  The alpha-galactomannan Davanat binds galectin-1 at a site different from the conventional galectin carbohydrate binding domain.

Authors:  Michelle C Miller; Anatole Klyosov; Kevin H Mayo
Journal:  Glycobiology       Date:  2009-06-18       Impact factor: 4.313

Review 10.  Galectin-1 as a potential cancer target.

Authors:  G A Rabinovich
Journal:  Br J Cancer       Date:  2005-04-11       Impact factor: 7.640

View more
  10 in total

1.  Intra- and intermolecular interactions of human galectin-3: assessment by full-assignment-based NMR.

Authors:  Hans Ippel; Michelle C Miller; Sabine Vértesy; Yi Zheng; F Javier Cañada; Dennis Suylen; Kimiko Umemoto; Cecilia Romanò; Tilman Hackeng; Guihua Tai; Hakon Leffler; Jürgen Kopitz; Sabine André; Dieter Kübler; Jesús Jiménez-Barbero; Stefan Oscarson; Hans-Joachim Gabius; Kevin H Mayo
Journal:  Glycobiology       Date:  2016-02-23       Impact factor: 4.313

2.  Altered galectin-1 serum levels in patients diagnosed with high-grade glioma.

Authors:  Tina Verschuere; Matthias Van Woensel; Steffen Fieuws; Florence Lefranc; Veronique Mathieu; Robert Kiss; Stefaan W Van Gool; Steven De Vleeschouwer
Journal:  J Neurooncol       Date:  2013-07-04       Impact factor: 4.130

3.  Binding of polysaccharides to human galectin-3 at a noncanonical site in its carbohydrate recognition domain.

Authors:  Michelle C Miller; Hans Ippel; Dennis Suylen; Anatole A Klyosov; Peter G Traber; Tilman Hackeng; Kevin H Mayo
Journal:  Glycobiology       Date:  2016-01       Impact factor: 4.313

4.  Novel polysaccharide binding to the N-terminal tail of galectin-3 is likely modulated by proline isomerization.

Authors:  Michelle C Miller; Y Zheng; Jingmin Yan; Yifa Zhou; Guihua Tai; Kevin H Mayo
Journal:  Glycobiology       Date:  2017-11-01       Impact factor: 4.313

5.  Glycodendrimers: tools to explore multivalent galectin-1 interactions.

Authors:  Jonathan M Cousin; Mary J Cloninger
Journal:  Beilstein J Org Chem       Date:  2015-05-12       Impact factor: 2.883

Review 6.  Galectins as Molecular Targets for Therapeutic Intervention.

Authors:  Ruud P M Dings; Michelle C Miller; Robert J Griffin; Kevin H Mayo
Journal:  Int J Mol Sci       Date:  2018-03-19       Impact factor: 5.923

7.  PLG-007 and Its Active Component Galactomannan-α Competitively Inhibit Enzymes That Hydrolyze Glucose Polymers.

Authors:  Michelle C Miller; Aurelio J Dregni; David Platt; Kevin H Mayo
Journal:  Int J Mol Sci       Date:  2022-07-13       Impact factor: 6.208

8.  Regression of fibrosis and reversal of cirrhosis in rats by galectin inhibitors in thioacetamide-induced liver disease.

Authors:  Peter G Traber; Hsin Chou; Eliezer Zomer; Feng Hong; Anatole Klyosov; Maria-Isabel Fiel; Scott L Friedman
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

9.  Low or No Inhibitory Potency of the Canonical Galectin Carbohydrate-binding Site by Pectins and Galactomannans.

Authors:  John Stegmayr; Adriana Lepur; Barbro Kahl-Knutson; Matilde Aguilar-Moncayo; Anatole A Klyosov; Robert A Field; Stina Oredsson; Ulf J Nilsson; Hakon Leffler
Journal:  J Biol Chem       Date:  2016-04-26       Impact factor: 5.157

10.  Galectin-3 Regulates Atrial Fibrillation Remodeling and Predicts Catheter Ablation Outcomes.

Authors:  Yoshio Takemoto; Rafael J Ramirez; Miki Yokokawa; Kuljeet Kaur; Daniela Ponce-Balbuena; Mohamad C Sinno; B Cicero Willis; Hamid Ghanbari; Steven R Ennis; Guadalupe Guerrero-Serna; Bettina C Henzi; Rakesh Latchamsetty; Roberto Ramos-Mondragon; Hassan Musa; Raphael P Martins; Sandeep V Pandit; Sami F Noujaim; Thomas Crawford; Krit Jongnarangsin; Frank Pelosi; Frank Bogun; Aman Chugh; Omer Berenfeld; Fred Morady; Hakan Oral; José Jalife
Journal:  JACC Basic Transl Sci       Date:  2016-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.